Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study
Overview
Authors
Affiliations
Background: Metabolites of the tryptophan-kynurenine pathway (i.e., tryptophan, kynurenine, kynurenic acid, quinolinic acid, 3-hydroxyanthranilic) may be associated with diabetes development. Using a case-cohort design nested in the Prevención con Dieta Mediterránea (PREDIMED) study, we studied the associations of baseline and 1-year changes of these metabolites with incident type 2 diabetes (T2D).
Methods: Plasma metabolite concentrations were quantified via LC-MS for n = 641 in a randomly selected subcohort and 251 incident cases diagnosed during 3.8 years of median follow-up. Weighted Cox models adjusted for age, sex, body mass index, and other T2D risk factors were used.
Results: Baseline tryptophan was associated with higher risk of incident T2D (hazard ratio = 1.29; 95% CI, 1.04-1.61 per SD). Positive changes in quinolinic acid from baseline to 1 year were associated with a higher risk of T2D (hazard ratio = 1.39; 95% CI, 1.09-1.77 per SD). Baseline tryptophan and kynurenic acid were directly associated with changes in homeostatic model assessment for insulin resistance (HOMA-IR) from baseline to 1 year. Concurrent changes in kynurenine, quinolinic acid, 3-hydroxyanthranilic acid, and kynurenine/tryptophan ratio were associated with baseline-to-1-year changes in HOMA-IR.
Conclusions: Baseline tryptophan and 1-year increases in quinolinic acid were positively associated with incident T2D. Baseline and 1-year changes in tryptophan metabolites predicted changes in HOMA-IR. Tryptophan levels may initially increase and then deplete as diabetes progresses in severity.
Alsaleem M, Al-Kuraishy H, Al-Gareeb A, Abdel-Fattah M, Alrouji M, Al-Harchan N J Cell Mol Med. 2025; 29(5):e70378.
PMID: 40040308 PMC: 11880132. DOI: 10.1111/jcmm.70378.
Amin F, Ahmad S, Wasim M, Khan A, Manzoor Arain F, Batool Z J Tradit Chin Med. 2025; 45(1):49-56.
PMID: 39957158 PMC: 11764942. DOI: 10.19852/j.cnki.jtcm.2025.01.005.
Nutritional intake of micronutrient and macronutrient and type 2 diabetes: machine learning schemes.
Rashidmayvan M, Mansoori A, Derakhshan-Nezhad E, Tanbakuchi D, Sangin F, Mohammadi-Bajgiran M J Health Popul Nutr. 2025; 44(1):31.
PMID: 39920736 PMC: 11806732. DOI: 10.1186/s41043-024-00712-2.
Bin Eshaq S, Taneera J, Anjum S, Mohammed A, Semreen M, Alzoubi K Cells. 2025; 14(1.
PMID: 39791758 PMC: 11720184. DOI: 10.3390/cells14010057.
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer.
Yan J, Chen D, Ye Z, Zhu X, Li X, Jiao H Mol Cancer. 2024; 23(1):241.
PMID: 39472902 PMC: 11523861. DOI: 10.1186/s12943-024-02164-y.